Discontinuation report MINT-RIZATRIPTAN ODT

Last updated on 2017-07-01 History
Report ID 13544
Drug Identification Number 02439573
Brand name MINT-RIZATRIPTAN ODT
Common or Proper name Rizatriptan Benzoate
Company Name MINT PHARMACEUTICALS INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size Blister pack of 6 Tablets
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-06-30
Remaining supply date 2017-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-06-21 English Compare
v2 2017-06-21 French Compare
v3 2017-06-21 French Compare
v4 2017-06-21 English Compare
v5 2017-06-21 English Compare
v6 2017-06-21 French Compare
v7 2017-07-01 English Compare

Showing 1 to 7 of 7